Literature DB >> 20378731

Epithelial stress and apoptosis underlie Hermansky-Pudlak syndrome-associated interstitial pneumonia.

Poornima Mahavadi1, Martina Korfei, Ingrid Henneke, Gerhard Liebisch, Gerd Schmitz, Bernadette R Gochuico, Philipp Markart, Saverio Bellusci, Werner Seeger, Clemens Ruppert, Andreas Guenther.   

Abstract

RATIONALE: The molecular mechanisms underlying Hermansky-Pudlak syndrome-associated interstitial pneumonia (HPSIP) are poorly understood but, as in idiopathic pulmonary fibrosis, may be linked to chronic alveolar epithelial type II cell (AECII) injury.
OBJECTIVES: We studied the development of fibrosis and the role of AECII injury in various murine models of HPS.
METHODS: HPS1, HPS2, and HPS6 monomutant mice, and HPS1/2 and HPS1/6 double-mutant and genetic background mice, were killed at 3 and 9 months of age. Quantitative morphometry was undertaken in lung sections stained with hemalaun-eosin. The extent of lung fibrosis was assessed by trichrome staining and hydroxyproline measurement. Surfactant lipids were analyzed by electrospray ionization mass spectrometry. Surfactant proteins, apoptosis, and lysosomal and endoplasmic reticulum stress markers were studied by Western blotting and immunohistochemistry. Cell proliferation was measured by water-soluble tetrazolium salt-1 and bromodeoxyuridine assays.
MEASUREMENTS AND MAIN RESULTS: Spontaneous and slowly progressive HPSIP was observed in HPS1/2 double mutants, but not in other HPS mutants, with subpleural onset at 3 months and full-blown fibrosis at 9 months. In these mice, extensive surfactant abnormalities were encountered in AECII and were paralleled by early lysosomal stress (cathepsin D induction), late endoplasmic reticulum stress (activating transcription factor-4 [ATF4], C/EBP homologous protein [CHOP] induction), and marked apoptosis. These findings were fully corroborated in human HPSIP. In addition, cathepsin D overexpression resulted in apoptosis of MLE-12 cells and increased proliferation of NIH 3T3 fibroblasts incubated with conditioned medium of the transfected cells.
CONCLUSIONS: Extensively impaired surfactant trafficking and secretion underlie lysosomal and endoplasmic reticulum stress with apoptosis of AECII in HPSIP, thereby causing the development of HPSIP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20378731      PMCID: PMC2913235          DOI: 10.1164/rccm.200909-1414OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  59 in total

1.  The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress.

Authors:  K Kågedal; U Johansson; K Ollinger
Journal:  FASEB J       Date:  2001-07       Impact factor: 5.191

2.  Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis.

Authors:  A Günther; R Schmidt; F Nix; M Yabut-Perez; C Guth; S Rosseau; C Siebert; F Grimminger; H Morr; H G Velcovsky; W Seeger
Journal:  Eur Respir J       Date:  1999-09       Impact factor: 16.671

3.  Involvement of cathepsin H in the processing of the hydrophobic surfactant-associated protein C in type II pneumocytes.

Authors:  Frank Brasch; Anja Ten Brinke; Georg Johnen; Matthias Ochs; Nadine Kapp; Klaus M Müller; Michael F Beers; Heinz Fehrenbach; Joachim Richter; Joseph J Batenburg; Frank Bühling
Journal:  Am J Respir Cell Mol Biol       Date:  2002-06       Impact factor: 6.914

4.  The Hermansky-Pudlak syndrome 1 (HPS1) and HPS2 genes independently contribute to the production and function of platelet dense granules, melanosomes, and lysosomes.

Authors:  Lijun Feng; Edward K Novak; Lisa M Hartnell; Juan S Bonifacino; Lucy M Collinson; Richard T Swank
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

5.  Altered stability of pulmonary surfactant in SP-C-deficient mice.

Authors:  S W Glasser; M S Burhans; T R Korfhagen; C L Na; P D Sly; G F Ross; M Ikegami; J A Whitsett
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

6.  Interstitial pneumonia in Hermansky-Pudlak syndrome: significance of florid foamy swelling/degeneration (giant lamellar body degeneration) of type-2 pneumocytes.

Authors:  Y Nakatani; N Nakamura; J Sano; Y Inayama; N Kawano; S Yamanaka; Y Miyagi; Y Nagashima; C Ohbayashi; M Mizushima; T Manabe; M Kuroda; T Yokoi; O Matsubara
Journal:  Virchows Arch       Date:  2000-09       Impact factor: 4.064

7.  Hermansky-Pudlak syndrome is caused by mutations in HPS4, the human homolog of the mouse light-ear gene.

Authors:  Tamio Suzuki; Wei Li; Qing Zhang; Amna Karim; Edward K Novak; Elena V Sviderskaya; Simon P Hill; Dorothy C Bennett; Alex V Levin; H Karel Nieuwenhuis; Chin-To Fong; Claudio Castellan; Bianca Miterski; Richard T Swank; Richard A Spritz
Journal:  Nat Genet       Date:  2002-02-11       Impact factor: 38.330

Review 8.  Disorders of vesicles of lysosomal lineage: the Hermansky-Pudlak syndromes.

Authors:  M Huizing; W A Gahl
Journal:  Curr Mol Med       Date:  2002-08       Impact factor: 2.222

9.  Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome.

Authors:  William A Gahl; Mark Brantly; James Troendle; Nilo A Avila; Antonio Padua; Carlos Montalvo; Hilda Cardona; Karim Anton Calis; Bernadette Gochuico
Journal:  Mol Genet Metab       Date:  2002-07       Impact factor: 4.797

10.  Altered intracellular redox status in Gaucher disease fibroblasts and impairment of adaptive response against oxidative stress.

Authors:  Marta Deganuto; Maria Gabriela Pittis; Alex Pines; Silvia Dominissini; Mark R Kelley; Rodolfo Garcia; Franco Quadrifoglio; Bruno Bembi; Gianluca Tell
Journal:  J Cell Physiol       Date:  2007-07       Impact factor: 6.384

View more
  39 in total

Review 1.  Genetic interstitial lung disease.

Authors:  Megan Stuebner Devine; Christine Kim Garcia
Journal:  Clin Chest Med       Date:  2011-12-06       Impact factor: 2.878

2.  Pirfenidone for the treatment of Hermansky-Pudlak syndrome pulmonary fibrosis.

Authors:  Kevin O'Brien; James Troendle; Bernadette R Gochuico; Thomas C Markello; Jose Salas; Hilda Cardona; Jianhua Yao; Isa Bernardini; Richard Hess; William A Gahl
Journal:  Mol Genet Metab       Date:  2011-03-21       Impact factor: 4.797

3.  Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease.

Authors:  Bernadette R Gochuico; Marjan Huizing; Gretchen A Golas; Charles D Scher; Maria Tsokos; Stacey D Denver; Melissa J Frei-Jones; William A Gahl
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

4.  Multiple ways to die: delineation of the unfolded protein response and apoptosis induced by Surfactant Protein C BRICHOS mutants.

Authors:  Jean Ann Maguire; Surafel Mulugeta; Michael F Beers
Journal:  Int J Biochem Cell Biol       Date:  2011-10-13       Impact factor: 5.085

Review 5.  Is Progression of Pulmonary Fibrosis due to Ventilation-induced Lung Injury?

Authors:  Richard K Albert; Bradford Smith; Carrie E Perlman; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2019-07-15       Impact factor: 21.405

6.  Hermansky-Pudlak syndrome interstitial pneumonia: it's the epithelium, stupid!

Authors:  Poornima Mahavadi; Andreas Guenther; Bernadette R Gochuico
Journal:  Am J Respir Crit Care Med       Date:  2012-11-15       Impact factor: 21.405

7.  Early alveolar epithelial dysfunction promotes lung inflammation in a mouse model of Hermansky-Pudlak syndrome.

Authors:  Elena N Atochina-Vasserman; Sandra R Bates; Peggy Zhang; Helen Abramova; Zhenguo Zhang; Linda Gonzales; Jian-Qin Tao; Bernadette R Gochuico; William Gahl; Chang-Jiang Guo; Andrew J Gow; Michael F Beers; Susan Guttentag
Journal:  Am J Respir Crit Care Med       Date:  2011-08-15       Impact factor: 21.405

8.  An Official American Thoracic Society Workshop Report: Translational Research in Rare Respiratory Diseases.

Authors:  Arnold S Kristof; Basil J Petrof; Qutayba Hamid; Martin Kolb; Jennifer S Landry; Alex MacKenzie; Francis X McCormack; Inga J Murawski; Joel Moss; Frank Rauch; Ivan O Rosas; Adam J Shapiro; Benjamin M Smith; David Y Thomas; Bruce C Trapnell; Lisa R Young; Maimoona A Zariwala
Journal:  Ann Am Thorac Soc       Date:  2017-08

Review 9.  Pulmonary Fibrosis in Hermansky-Pudlak Syndrome.

Authors:  Glenn W Vicary; Yeidyly Vergne; Alberto Santiago-Cornier; Lisa R Young; Jesse Roman
Journal:  Ann Am Thorac Soc       Date:  2016-10

10.  The alveolar epithelium determines susceptibility to lung fibrosis in Hermansky-Pudlak syndrome.

Authors:  Lisa R Young; Peter M Gulleman; James P Bridges; Timothy E Weaver; Gail H Deutsch; Timothy S Blackwell; Francis X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2012-10-04       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.